Age-related Macular Degeneration: From Clinic to Genes and Back to Patient Management

This edited book focuses on the recent advances in our understanding of age-related macular degeneration (AMD), combining epidemiology and clinical diagnosis, with genetics and immunological aspects, and the role of proteostasis and mitochondria. AMD is a leading cause of blindness worldwide, and the number of cases is projected to double by 2050. The book brings together state-of-the-art basic science knowledge with clinically relevant findings and addresses the challenges for future research in AMD. The intersection of different disciplines offers potential areas for further investigations to reduce the burden of blindness from AMD.

Format: Paperback / softback
Length: 314 pages
Publication date: 15 April 2022
Publisher: Springer Nature Switzerland AG

This edited book delves into the latest advancements in our understanding of age-related macular degeneration (AMD), encompassing epidemiology, clinical diagnosis, genetics, immunology, proteostasis, and mitochondria. It then explores innovative therapies, including stem cell-based approaches, to combat this prevalent and rapidly increasing cause of blindness worldwide. AMD, projected to double from 2.07 million to 5.44 million individuals in the United States by 2050, affects 288 million people globally by 2040. This disease not only impairs vision but also has significant socioeconomic consequences for affected individuals, their families, and society as a whole.

The purpose of this book is to bring together the state-of-the-art basic science knowledge with clinically relevant findings to address the challenges and opportunities in AMD research. By fostering interdisciplinary collaboration, the book aims to identify potential areas for further investigations to reduce the burden of blindness caused by AMD.

The book is designed to appeal to a wide audience, including clinicians, scientists, students, and fellows. It provides a comprehensive overview of AMD, its pathogenesis, diagnosis, and treatment, while also exploring emerging therapies and the potential for breakthroughs in the future. Each chapter is authored by experts in the field, ensuring that the content is up-to-date, authoritative, and accessible.

In conclusion, this edited book is a valuable resource for anyone interested in AMD research, treatment, and prevention. It offers a comprehensive perspective on the latest advancements in the field and provides a roadmap for future investigations to improve the lives of individuals affected by this blinding disease.

Weight: 618g
Dimension: 254 x 178 (mm)
ISBN-13: 9783030660161
Edition number: 1st ed. 2021